Anhui Fengyuan Pharmaceutical News

Fengyuan Pharmaceutical: An indicative announcement on the 2022 Restricted Stock Incentive Plan to lift the listing and circulation of restricted shares during the second lifting period

Oct 15 12:00 ET

Fengyuan Pharmaceutical: Legal Opinion of Anhui Jingqiao Law Firm on the Company\'s 2022 Restricted Stock Incentive Plan\'s Second Cancellation Period, Achievements in Releasing Sales Restriction Conditions, Adjusting Repurchase Prices, etc.

Oct 9 12:00 ET

Fengyuan Pharmaceutical: Announcement on the achievements of the 2022 Restricted Stock Incentive Plan to grant shares during the second period of lifting the sales restrictions and lifting the sales restrictions

Oct 9 12:00 ET

Fengyuan Pharmaceutical: Announcement on Repurchase and Cancellation of Some Restricted Shares

Oct 9 12:00 ET

Fengyuan Pharmaceutical: Legal Opinion of Anhui Jingqiao Law Firm on the Company\'s 2022 Restricted Stock Incentive Plan to Repurchase and Cancel Some Restricted Shares

Oct 9 12:00 ET

Fengyuan Pharmaceutical: Announcement on Adjusting the 2022 Restricted Stock Incentive Plan Ticket Repurchase Price

Oct 9 12:00 ET

Fengyuan Pharmaceutical: Voluntary Information Disclosure Notice on Receipt of 2023 Profit Dividends from Huishang Bank

Aug 27 12:00 ET

Anhui Fengyuan Pharmaceutical: 2023 Annual Equity Distribution Implementation Notice

May 29 12:00 ET

Anhui Fengyuan Pharmaceutical: About the 2023 Profit Distribution and Capital Provident Fund Share Capital Transfer Plan

Apr 25 12:00 ET

Fengyuan Pharmaceutical: Announcement on shareholders' agreed repurchase securities transactions and changes in shareholding ratio of more than 1%

Mar 26 12:00 ET

Fengyuan Pharmaceutical: Announcement on the completion of the repurchase and cancellation of some restricted shares and changes in share capital

Dec 27, 2023 11:00 ET

Fengyuan Pharmaceutical: Announcement on shareholders\' agreed repurchase securities transactions and changes in shareholding ratio of more than 1%

Dec 5, 2023 11:00 ET

Fengyuan Pharmaceutical: An indicative announcement on the 2022 Restricted Stock Incentive Plan, the first lifting of the sales restriction period and the lifting of the listing and circulation of restricted shares

Oct 16, 2023 12:00 ET

Fengyuan Pharmaceutical: Anhui Jingqiao Law Firm\'s legal opinion on matters related to the company\'s 2022 restricted stock incentive plan, the first lifting of sales restrictions, sales conditions, and the adjustment of repurchase prices

Oct 9, 2023 12:00 ET

Fengyuan Pharmaceutical: Announcement on the achievements of the 2022 Restricted Stock Incentive Plan to grant stocks the first period to lift sales restrictions and lift sales restrictions

Oct 9, 2023 12:00 ET

Fengyuan Pharmaceutical: Notice on the repurchase and cancellation of some restricted shares

Oct 9, 2023 12:00 ET

Fengyuan Pharmaceutical: Notice on Adjusting the 2022 Restricted Stock Incentive Plan Ticket Repurchase Price

Oct 9, 2023 12:00 ET

Fengyuan Pharmaceutical: Anhui Jingqiao Law Firm\'s legal opinion on the company\'s 2022 restricted stock incentive plan to repurchase and cancel some restricted shares

Oct 9, 2023 12:00 ET

Fengyuan Pharmaceutical: Notice on Termination of Issuance of Shares to Purchase Assets and Raise Supporting Funds and Related Transactions

Jun 20, 2023 12:00 ET

Fengyuan Pharmaceutical: 2022 Annual Equity Distribution Implementation Notice

Jun 8, 2023 12:00 ET